ArticleCancers2026

Comparison Between Alpelisib Plus Endocrine Therapy and Everolimus Plus Endocrine Therapy After CDK4/6 Inhibitors Progression in Patients with

Sotiris Loizidis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.